2-47800278-C-G
Variant summary
Our verdict is Likely pathogenic. Variant got 7 ACMG points: 7P and 0B. PM2PP3_StrongPP5
The NM_000179.3(MSH6):c.2295C>G(p.Cys765Trp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_000179.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_pathogenic. Variant got 7 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 34
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Hereditary cancer-predisposing syndrome Pathogenic:1
The p.C765W variant (also known as c.2295C>G), located in coding exon 4 of the MSH6 gene, results from a C to G substitution at nucleotide position 2295. The cysteine at codon 765 is replaced by tryptophan, an amino acid with highly dissimilar properties. The p.C765W alteration was identified in trans with another MSH6 alteration (p.V878A) in patient diagnosed with colon cancer at age 31, and this patient’s mother, also a carrier of p.C765W, was diagnosed with endometrial cancer at age 60 (Plaschke J et al. Eur. J. Hum. Genet., 2006 May;14:561-6). This alteration was also identified in an individual whose colorectal tumor demonstrated markedly reduced MSH6 protein expression on immunohistochemistry (IHC)(Ambry internal data). Based on an internal structural assessment, this alteration significantly disrupts the structure of the connector domain (Warren JJ et al. Mol. Cell, 2007 May;26:579-92). This variant was not reported in population-based cohorts in the Genome Aggregation Database (gnomAD) (Lek M et al. Nature, 2016 08;536:285-91). This amino acid position is highly conserved in available vertebrate species. In addition, this alteration is predicted to be deleterious by in silico analysis. In addition, the CoDP in silico tool predicts this alteration is likely to impair molecular function, with a score of 1.000 (Terui H et al. J. Biomed. Sci. 2013;20:25). This alteration was also predicted to be pathogenic by the PON-MMR consensus-based prediction model (Ali H et al. Hum. Mutat., 2012 Apr;33:642-50). Based on the majority of available evidence to date, this variant is likely to be pathogenic. -
Hereditary nonpolyposis colorectal neoplasms Uncertain:1
This variant has been observed in individual(s) with colon or uterine cancer (PMID: 16418736). ClinVar contains an entry for this variant (Variation ID: 89265). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. An algorithm developed specifically for the MSH6 gene suggests that this missense change is likely to be deleterious (PMID: 22290698, 23621914). However, this prediction has not been confirmed by published functional studies and its clinical significance is uncertain. This variant is not present in population databases (ExAC no frequency). This sequence change replaces cysteine with tryptophan at codon 765 of the MSH6 protein (p.Cys765Trp). The cysteine residue is highly conserved and there is a large physicochemical difference between cysteine and tryptophan. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at